U010 GI Skin: Cutaneous Manifestations of Gastrointestinal Inflammatory Disorders
DESCRIPTION
This session focuses on the presentation, diagnosis, and multi-disciplinary management of cutaneous manifestations of gastrointestinal inflammatory conditions. Inflammatory bowel disease impacts the skin with specific, reactive, and associated conditions. In addition, other inflammatory conditions may impact both the skin and GI tract including dermatoses associated with stomas. This session is geared toward general dermatologists who are evaluating and managing these patients in conjunction with the gastroenterology team and collaborating on their care.
LEARNING OBJECTIVES
Recognize and diagnose cutaneous manifestations of inflammatory gastrointestinal conditions
Evaluate patients with cutaneous manifestations of inflammatory gastrointestinal conditions and recognize when and how to initiate an evaluation for gastrointestinal disease based on the cutaneous presentation.
Collaborate with multi disciplinary providers to treat patients' cutaneous manifestations in the context of their gastrointestinal condition and treatment plan.
SCHEDULE
7:30 AM
Introduction and Overview
Alexandra P Charrow, MD, FAAD
7:31 AM
Drug rashes in IBD patients
Alexandra P Charrow, MD, FAAD
7:43 AM
Stomas- the basics and common associated dermatoses
Anagha Bangalore Kumar, MD, MBBS, FAAD
7:55 AM
MCD overview and perianal disease
Afsaneh Alavi, MD, FAAD
8:07 AM
Neutrophilic dermatoses in IBD and beyond
Bridget Shields, MD, FAAD
8:19 AM
Q&A
8:19 AM
Discussion
DIRECTOR
Afsaneh Alavi, MD, FAAD
CO-DIRECTOR
Alexandra P Charrow, MD, FAAD
SPEAKERS
Anagha Bangalore Kumar, MD, MBBS, FAAD
Bridget Shields, MD, FAAD
DISCLOSURES
Afsaneh Alavi, MD, FAAD
AbbVie – Advisory Board(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Fees); Alumis – Advisory Board(Honoraria); Avalo – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Investigator(Fees); Cantargia – Consultant (1099 relationship)(Fees); Dermatology Times (MMM MultiMedia Medical, LLC) – Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); InflaRx – Data Safety Monitoring Board(Honoraria); Leo Foundation – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); Zura Bio – Data Safety Monitoring Board(Honoraria);
Anagha Bangalore Kumar, MD, MBBS, FAAD
No financial relationships exist with ineligible companies.
Alexandra P Charrow, MD, FAAD
Avalo – Consultant (1099 relationship)(Fees); Dermatology Foundation – Investigator(Grants/Research Funding); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Fees), Investigator(No Compensation Received); Insmed – Investigator(No Compensation Received); Insmed Incorporated – Investigator(No Compensation Received); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(No Compensation Received); Sonoma Biotherapeutics – Investigator(No Compensation Received); UCB Pharma – Advisory Board(Honoraria); Wedbush Securities – Consultant (1099 relationship)(Honoraria);
Bridget Shields, MD, FAAD
Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria); UpToDate, Inc – Other(Honoraria);